Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Mollie Leoni

Chief Medical Officer at Kura Oncology, Inc. (KURA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 29SEC KURAKura Oncology, Inc. Sell Plan 12,448169,897 held (−7%) $10.50 $131K +1.0%
Sep 29SEC KURAKura Oncology, Inc. Sell Plan 28,802141,095 held (−17%) $10.75 $310K -1.4%
Jun 22SEC KURAKura Oncology, Inc. Sell Plan 84,929182,345 held (−32%) $9.82 $834K +7.9%
Jan 27SEC KURAKura Oncology, Inc. Sell 3,655271,799 held (−1%) $8.46 $31K +25.3%
Jan 27SEC KURAKura Oncology, Inc. Sell 2,233269,566 held (−1%) $8.46 $19K +25.3%
Jan 27SEC KURAKura Oncology, Inc. Sell 951268,615 held (−0%) $8.46 $8K +25.3%
Jan 27SEC KURAKura Oncology, Inc. Sell 1,341267,274 held (−0%) $8.46 $11K +25.3%
Nov 14SEC KURAKura Oncology, Inc. Sell 15,485225,454 held (−6%) $11.18 $173K -5.2%
  • Sell

    Chief Medical Officer Mollie Leoni sold $131K of KURA at $10.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Mollie Leoni sold $310K of KURA at $10.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Mollie Leoni sold $834K of KURA at $9.82 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.